메뉴 건너뛰기




Volumn 11, Issue 23, 2003, Pages 5059-5068

Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: Synthesis of ligands for somatostatin receptors

Author keywords

[No Author keywords available]

Indexed keywords

7 (BENZO[1,3]DIOXOL 5 YLOXY) 3' 4' DIHYDRO 2H QUINOLINE 1 (4 AMINOBUTAN 1 YL) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 (BENZO[1,3]DIOXOL 5 YLOXY) 3' 4' DIHYDRO 2H QUINOLINE 1 (4 BENZYL AMINO BUTAN 1 YL) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 (BENZO[1,3]DIOXOL 5 YLOXY) 3' 4' DIHYDRO 2H QUINOLINE 1 (BUTYL 1 YLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 HYDROXY 3',4' DIHYDRO 2H QUINOLINE 1 (BUTYL 1 YLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 PHENOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 AMINOBUTAN 1 YL) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 PHENOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 BENZYLAMINOBUTAN 1 YL) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 PHENOXY 3',4' DIHYDRO 2H QUINOLINE 1 (BUTYL 1 YLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 PHENOXY 3,4 DIHYDRO 2H QUINOLINE 1 (4 AMINO 1 YLBUTAN 1 ONE) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLINE 2',4' DIONE; 7 PHENOXY 3,4 DIHYDRO 2H QUINOLINE 1 (4 AMINO 1 YLBUTAN 1 ONE) 4 SPIRO 5' 1' METHYL 3' (1H INDOL 3 YLMETHYL)IMIDAZOLINE 2',4' DIONE TRIFLATE; 7 PHENOXY 3,4 DIHYDRO 2H QUINOLINE 1 (4 BENZYLAMINO 1 YLBUTAN 1 ONE) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLINE 2',4' DIONE; 7 PHENOXY 3,4 DIHYDRO 2H QUINOLINE 1 (4 OXO 1 YLBUTYLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLINE 2',4' DIONE; 7 PHENOXY 3,4 DIHYDRO 2H QUINOLINE 1 (4 OXO 1 YLBUTYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' METHYL 3' (1H INDOL 3 YLMETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER)IMIDAZOLE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 AMINOBUTAN 1 YL) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 BENZYLAMINOBUTAN 1 YL) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 BENZYLAMINOBUTAN 1 YL) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (4 BUTAN 1 YLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (AMINOBUTAN 1 YL) 4 SPIRO 5' 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1 (BUTYL 1 YLBENZYLCARBAMIC ACID TERT BUTYL ESTER) 4 SPIRO 5' 1' METHYL 3' [2 (1H INDOL 3 YL)ETHYL 1 CARBOXYLIC ACID TERT BUTYL ESTER]IMIDAZOLIDINE 2',4' DIONE; 7 TOLYLOXY 3',4' DIHYDRO 2H QUINOLINE 1' (1H INDOL 3 YLMETHYL) 3' METHYLIMIDAZOLIDINE 2',4' DIONE; HORMONE RECEPTOR STIMULATING AGENT; QUINOLINE DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

EID: 0242266516     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.08.022     Document Type: Article
Times cited : (30)

References (24)
  • 1
    • 0025409471 scopus 로고
    • (a) . For some reviews on this topic see: Ball J.B., Alewood P.R. J. Mol. Rec. 2:1990;55 (b) Olson G.L., Bolin D.R., Bonner M.P., Bos M., Cook C.M., Fry D., Graves B.J., Hatada M., Hill D.E., Kahn M., Madison V.S., Rusiecki V.K., Sarabu R., Sepinwall J., Vincent G.P., Voss M.E. J. Med. Chem. 21:1993;3041 (c) Adang A.E.P., Hermkens P.H.H., Linders J.T.M., Ottenheijm H.C.J., van Staveren C.J. Recl. Trav. Chem. Pays-Bas. 113:1994;63.
    • (1990) J. Mol. Rec. , vol.2 , pp. 55
    • Ball, J.B.1    Alewood, P.R.2
  • 3
    • 0005449318 scopus 로고
    • For some reviews on this topic see:
    • (a) . For some reviews on this topic see: Ball J.B., Alewood P.R. J. Mol. Rec. 2:1990;55 (b) Olson G.L., Bolin D.R., Bonner M.P., Bos M., Cook C.M., Fry D., Graves B.J., Hatada M., Hill D.E., Kahn M., Madison V.S., Rusiecki V.K., Sarabu R., Sepinwall J., Vincent G.P., Voss M.E. J. Med. Chem. 21:1993;3041 (c) Adang A.E.P., Hermkens P.H.H., Linders J.T.M., Ottenheijm H.C.J., van Staveren C.J. Recl. Trav. Chem. Pays-Bas. 113:1994;63.
    • (1994) Recl. Trav. Chem. Pays-Bas , vol.113 , pp. 63
    • Adang, A.E.P.1    Hermkens, P.H.H.2    Linders, J.T.M.3    Ottenheijm, H.C.J.4    Van Staveren, C.J.5
  • 23
    • 0027146390 scopus 로고
    • All assays were performed by MDS Pharma Services (
    • Feniuk W., Dimech J., Humphrey P.P. Br. J. Pharmacol. 110:1993;1156. All assays were performed by MDS Pharma Services ( www.mdsps.com ).
    • (1993) Br. J. Pharmacol. , vol.110 , pp. 1156
    • Feniuk, W.1    Dimech, J.2    Humphrey, P.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.